The United States Food and Drug Administration (FDA) recently approved Opdivo, an advanced lung cancer drug. Opdivo is the first immuno-oncology drug therapy for patients with lung cancer. Mesothelioma and lung cancer are caused by exposure and inhalation of dangerous...